- Home
- ADCT vs USCB Comparison
ADCT vs USCB Comparison
Compare ADCT & USCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- USCB
- Stock Information
- Founded
- ADCT 2011
- USCB 2002
- Country
- ADCT Switzerland
- USCB United States
- Employees
- ADCT N/A
- USCB N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- USCB Major Banks
- Sector
- ADCT Health Care
- USCB Finance
- Exchange
- ADCT Nasdaq
- USCB Nasdaq
- Market Cap
- ADCT 380.2M
- USCB 313.1M
- IPO Year
- ADCT 2020
- USCB 2021
- Fundamental
- Price
- ADCT $3.95
- USCB $17.39
- Analyst Decision
- ADCT Strong Buy
- USCB Strong Buy
- Analyst Count
- ADCT 6
- USCB 3
- Target Price
- ADCT $7.60
- USCB $22.00
- AVG Volume (30 Days)
- ADCT 860.1K
- USCB 26.1K
- Earning Date
- ADCT 11-10-2025
- USCB 10-23-2025
- Dividend Yield
- ADCT N/A
- USCB 2.33%
- EPS Growth
- ADCT N/A
- USCB 50.82
- EPS
- ADCT N/A
- USCB 1.57
- Revenue
- ADCT $77,246,000.00
- USCB $92,331,000.00
- Revenue This Year
- ADCT $11.78
- USCB $25.60
- Revenue Next Year
- ADCT $4.83
- USCB $11.20
- P/E Ratio
- ADCT N/A
- USCB $10.93
- Revenue Growth
- ADCT 15.73
- USCB 28.61
- 52 Week Low
- ADCT $1.05
- USCB $15.00
- 52 Week High
- ADCT $4.80
- USCB $21.86
- Technical
- Relative Strength Index (RSI)
- ADCT 44.05
- USCB 53.22
- Support Level
- ADCT $3.92
- USCB $17.00
- Resistance Level
- ADCT $4.80
- USCB $17.73
- Average True Range (ATR)
- ADCT 0.23
- USCB 0.37
- MACD
- ADCT -0.06
- USCB 0.02
- Stochastic Oscillator
- ADCT 4.32
- USCB 71.52
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
About USCB USCB Financial Holdings Inc.
USCB Financial Holdings Inc is a community bank. Through its network of branches and its online banking platform, it offers customers a wide range of financial products and services such as Personal and Business Checking, Savings, Credit Cards, and Real Estate Loans.